Data di Pubblicazione:
2009
Citazione:
Chlamydophila pneumoniae / F. Blasi , P. Tarsia, S. Aliberti. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - 15:1(2009), pp. 29-35.
Abstract:
Chlamydophila pneumoniae infection is ubiquitous. It accounts for 10% of community-acquired pneumonias and 5% of cases of pharyngitis,
bronchitis and sinusitis in both immunocompetent and immunocompromised hosts. It is also involved in exacerbations of chronic bronchitis
and asthma. Moreover, C. pneumoniae has been reported as a possible cause of atherosclerosis and central nervous system disorders.
The current reference standard for serological diagnosis of acute infection is microimmunofluorescence testing, although
molecular detection techniques may well become reference diagnostic tests in the near future. Tetracyclines and erythromycin show
good in vitro activity, and so far have been the most commonly employed drugs in the treatment of C. pneumoniae infection. New macrolides,
ketolides and fluoroquinolones are other potentially effective drugs. This review analyses the most recent data concerning the
involvement of C. pneumoniae in human diseases.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Chlamydophila pneumoniae; Diagnostic methods; Epidemiology; Review; Treatment
Elenco autori:
F. Blasi , P. Tarsia, S. Aliberti
Link alla scheda completa: